Investigación

Enfermedades Infecciosas y Microbioma

Buscador de publicaciones

Publicaciones

  • Pons-Tomas, Gemma, Hernandez-Garcia, Maria, Mele-Casas, Maria, Fernández de Sevilla-Estrach M, Launes-Montana C, Girona M, Rios-Barnés M, Bassat Q, Ajanovic, Sara, Cubells M, Claverol J, Penela-Sanchez, Daniel, Jou-Munoz C, Manuel Monsonis Cabedo, Esteva-Afonso C, Fassanella, Assumpta, Cuadras-Palleja D, Munoz-Almagro C, Jordán-García I, Fortuny-Guasch C, García-García JJ and Fumadó V.

    Clinical Characterization, Transmissibility, and Seroconversion of SARS-CoV-2 Infection in Children (before the Start of Vaccination) in the Barcelona Metropolitan Region (Spain)

    Journal of Pediatric Infectious Diseases . 19(05): 251-259.

    [doi:10.1055/s-0044-1787676]

  • Henares-Bonilla D, Monsalvez V, Brotons-de los Reyes P, Machado ML, Capilla S, Gomila-Grange A, Bierge P, Cubero M, Q Pich O, Requena-Méndez A, Munoz-Almagro C and Gasch O.

    Human gut microbiota composition associated with international travels

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 61: 102747-102747.

    [doi:10.1016/j.tmaid.2024.102747]

  • Alejandre-Galobardes C, Penela-Sánchez, D, Alsina, J, Agüera, M, Soler-García a, Moussalam, S, Munoz-Almagro C, Brotons-de los Reyes P, Cambra-Lasaosa FJ, Forner, OR, Balaguer-Gargallo M, Launes-Montana C and Jordán-García I.

    Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care

    EUROPEAN JOURNAL OF PEDIATRICS . 183(9): 3897-3904.

    [doi:10.1007/s00431-024-05634-z]

  • Vinent-Genestar J, Auvity S, Christiansen N, Ekelund H, Huys L, McNulty HBØ, Pani M, Pires V, Pourroy B and Stoner N.

    European Association of Hospital Pharmacists (EAHP) guidance on the pharmacy handling of in vivo gene therapy medicinal products.

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY . 31(5): 390-402. Nº de citas: 1

    [doi:10.1136/ejhpharm-2023-004062]

  • Pons-Tomàs G, Pino-Ramirez RM, Soler-García a, Launes-Montana C, Irene Martínez de Albéniz, Rios-Barnés M, Melé-Casas M, Hernández-García M, Manuel Monsonis Cabedo, Gene-Giralt A, Fernández de Sevilla-Estrach M, García-García JJ, Fortuny-Guasch C and Fumadó V.

    Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations

    PATHOGENS . 13(8): .

    [doi:10.3390/pathogens13080622]

  • Pérez-Vega KA, Sanllorente A, Zomeño MD, Quindós A, Muñoz-Martínez J, Malcampo M, Aldea-Perona A, Hernáez Á, Lluansí A, Llirós M, Elias I, Elias-Masiques N, Aldeguer X, Muñoz D, Gaixas S, Blanchart G, Schröder H, Hernando-Redondo J, Carrón N, González-Torres P, Konstantinidou V, Fitó M and Castañer O.

    Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome

    Nutrients . 16(15): .

    [doi:10.3390/nu16152380]

  • Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A and Fortuny-Guasch C.

    Off-label use of dalbavancin in children: a case series

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 79(8): 2062-2067.

    [doi:10.1093/jac/dkae212]

  • Belman S, Lefrancq N, Nzenze S, Downs S, du Plessis M, Lo SW, McGee L, Madhi SA, von Gottberg A, Bentley SD and Salje H.

    Geographical migration and fitness dynamics of Streptococcus pneumoniae.

    Nature . 631(8020): 386-392. Nº de citas: 2

    [doi:10.1038/s41586-024-07626-3]

  • Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny-Guasch C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C and Ford D.

    D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years

    Contemporary Clinical Trials . 142: 107540-107540. Nº de citas: 3

    [doi:10.1016/j.cct.2024.107540]

  • Agüera M, Soler-García a, Alejandre C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rosell J, Climent C, Esteva-Afonso C, Fortuny-Guasch C, Fernández de Sevilla-Estrach M, García-García JJ, Brotons-de los Reyes P, Balaguer A, Estrada J, Jordán-García I, Munoz-Almagro C and Launes-Montana C.

    Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study

    PEDIATRIC ALLERGY AND IMMUNOLOGY . 35(6): . Nº de citas: 2

    [doi:10.1111/pai.14175]